FINANCIAL DISCLOSURES
Christine Funke, MD
Alcon consulting
Sight Sciences consulting
Mark Barakat, MD
AbbVie Inc - C
Adverum Biotech - CR
Alcon - C
Alimera - C
Allegro - C
Allergan - C
Annexon Biosciences - R
Apellis - B
Ribomic - R
Graybug - CR
Gyroscope Therapeutics - R
Kodiak Sciences - CR
Novartis - BCR
NeuBase - E
Ocular Therapeutix - C
Oculis - R
Opthea - CR
Stealth Biotherapeutics - R
Arctic Vision - C
Bausch and Lomb - C
Biogen - C
Clearside Biomedical - CR
Coherus Biosciences - C
EyePoint Pharma - CR
Gemini Therapeutics - R
Genentech - BCR
Roche - C
Outlook Therapeutics - C
Oxular - R
Oxurion - ER
Palatin Technologies - C
Regeneron - B
RegenxBio - CR
ReNeuron - R
RevOpsis Therapeutics - C
UnityBiotech - R
David Kay, MD
Nothing to Disclose
Neal Palejwala, MD
Nothing to Disclose